John Carreyrou, Bad Blood

The Financial Times & McKinsey Business Book of the Year
A New York Times Notable Book
A Washington Post Notable Book
 
One of the Best Books of 2018: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal

Bad Blood is the riveting exposé that traces the breathtaking rise and collapse of the multibillion-dollar biotech startup Theranos--told by John Carreyrou, the Pulitzer Prize-winning journalist who first broke the story and pursued it to the end, despite legal threats from the company's charismatic CEO.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron--a tale of ambition and hubris set amid the bold promises of Silicon Valley.

About the Author: John Carreyrou is a two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Carreyrou lives in Brooklyn with his wife and three children.